Biomarkers of opiate use

International Journal of Clinical Practice

Volumn 64, Issue 12, 2010, Pages 1712-1718

  Stefanidou, M ^a   Athanaselis, S ^a   Spiliopoulou, C ^a   Dona, A ^a   Maravelias, C ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; BIOLOGICAL MARKER; DIAMORPHINE; ILLICIT DRUG; MORPHINE; MORPHINE 6 ACETATE; OPIATE;

AUTOPSY; BLOOD CHEMISTRY; CANCER PAIN; DIAGNOSTIC ACCURACY; DRUG DEPENDENCE; DRUG METABOLISM; HUMAN; LABORATORY TEST; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SCREENING TEST; TOXICOLOGICAL PARAMETERS; URINALYSIS;

BIOLOGICAL MARKERS; HUMANS; MORPHINE DEPENDENCE; MORPHINE DERIVATIVES; OPIATE ALKALOIDS; OPIOID-RELATED DISORDERS; PAIN; SUBSTANCE ABUSE DETECTION;

EID: 78349257373     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02373.x     Document Type: Review

References (59)

1. Stefanidou M, Maravelias C, Dona A, Athanaselis S, Spiliopoulou H,. Toxicological investigation of drug-related cases in Greece: interpretation of analytical findings. Int J Toxicol 2007; 26: 231-6.
2. Jenkins AJ, Lavins ES,. 6-Acetylmorphine detection in postmortem cerebrospinal fluid. J Anal Toxicol 1998; 22: 173-5.
3. Drummer OH,. Postmortem toxicology of drugs of abuse. Forensic Sci Int 2004; 142: 101-13. Review.
4. Tamayo AC, Diaz-Zuluaga PA,. Management of opioid-induced bowel dysfunction in cancer patients. Support Care Cancer 2004; 12: 613-8.
5. Brunton L,. (1996) Agents affecting gastrointestinal water flux and motility; emesis and antiemetics bile acids and pancreatic enzymes. In:, Hardman J, ed. Goodman and Gilmans the Pharmacological Basis of Therapeutics, 9th edn. New York: McGraw Hill, pp. 917-25.
6. Vanegas G, Ripamonti C, Sbanotto A, De Conno F,. Side effects of morphine administration in cancer patients. Cancer Nurs 1998; 21: 289-97.
7. Walsh TD,. Prevention of opioid side effects. J Pain Symptom Manage 1990; 5: 362-7.
8. Starreved JS, Pols MA, Vam Wijk HJ, et al. The plain abdominal radiographs in the assessment of constipation. Gastroenterology 1990; 28: 335-8.
9. Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effect of oral morphine: an evidence based report. J Clin Oncol 2001; 19: 2542-54.
10. Bhaskaran M, Reddy K, Sharma S, et al. Morphine-induced degradation of the host defense barrier: role of macrophage injury. J Infect Dis 2001; 184: 1524-31.
11. Tubaro E, Borelli G, Croce C, Cavallo G, Santiageli C,. Effect of morphine on resistance to infection. J Infect Dis 1983; 148: 656-62.
12. Pelders MG, Ross JJ,. Poppy seeds: differences in morphine and codeine content and variation in inter-and intra-individual excretion. J Forensic Sci 1996; 41: 209-12.
13. Lo DS, Chua TH,. Poppy seeds: implications of consumption. Med Sci Law 1992; 32: 296-302.
14. Senn R,. (2000) Drug testing in the workplace: legal and ethical issues. In:, Hall S, ed. Proceedings of the American Society of Business and Behavioral Sciences Track Section of Management, February 17-21, 2000, Las Vegas, Vol. 7, No. 3. NV: Texas A&M University - Corpus Christi Publisher, pp. 115-20.
15. Cassella G, Wu AHB, Shaw R, Hill DW,. The analysis of thebaine in urine for the detection of poppy seed consumption. J Anal Toxicol 1997; 21: 376-83.
16. Moeller MR, Hammer K, Engel O,. Poppy seed consumption and toxicological analysis of blood and urine samples. Forensic Sci Int 2004; 143: 183-6.
17. Mandatory Guidelines for Federal Workplace Drug-Testing Programs, Federal Register, 69. 2004, pp. 19644-73. (accessed 15 January 2010).
18. Kintz P, Jamey C, Cirimele V, Brenneisen R, Ludes B,. Evaluation of acetylcodeine as a specific marker of illicit heroin in human hair. J Anal Toxicol 1998; 22: 425-9.
19. Pragst F, Spiegel K, Leuschner U, Hager A,. Detection of 6-acetylmorphine in vitreous humor and cerebrospinal fluid-comparison with urinary analysis for proving heroin administration in opiate fatalities. J Anal Toxicol 1999; 23: 168-72.
20. Moody DE, Cheever ML,. Evaluation of immunoassays for semiquantitative detection of cocaine and metabolites or heroin and metabolites in extracts of sweat patches. J Anal Toxicol 2001; 25: 190-7.
21. Morley SR, Forrest AR, Galloway JH,. Validation of meconin as a marker for illicit opiate use. J Anal Toxicol 2007; 31: 105-8.
22. Wolff K, Farrell M, Marsden J, et al. A review of biological indicators of illicit drug use, practical considerations and clinical usefulness. Addiction 1999; 94: 1279-98.
23. Paul BD, Shimomura ET, Smith ML,. A practical approach to determine cutoff concentrations for opiate testing with simultaneous detection of codeine, morphine and 6-acetylmorphine in urine. Clin Chem 1999; 45: 510-9.
24. Ceder G, Jones AW,. Concentration ratios of morphine to codeine in blood of impaired drivers as evidence of heroin use and not medication with codeine. Clin Chem 2001; 47: 1980-4.
25. Tassoni G, Cacaci C, Zampi M, Froldi R,. Bile analysis in heroin overdose. J Forensic Sci 2007; 52: 1405-7.
26. Wyman J, Bultman S,. Postmortem distribution of heroin metabolites in femoral blood, liver, cerebrospinal fluid, and vitreous humor. J Anal Toxicol 2004; 28: 260-3.
27. Antonides HM, Kiely ER, Marinetti LJ,. Vitreous fluid quantification of opiates, cocaine, and benzoylecgonine: comparison of calibration curves in both blood and vitreous matrices with corresponding concentrations in blood. J Anal Toxicol 2007; 31: 469-76.
28. Baselt RC,. Disposition of Toxic Drugs and Chemicals in man, 7th edn. Foster City, Davis, CA: Biomedical Publications, 2004.
29. Moffat AC, Osselton MD, Widdop B, eds. Clarkes Analysis of Drugs and Poisons. London: Pharmaceutical Press, 2004.
30. Wolff K, Rostami-Hodjegan A, Shires S, et al. The pharmacokinetics of methadone in healthy subjects and opiate users. Br J Clin Pharmacol 1997; 44: 325-34.
31. Jenkins AJ, Cone EJ,. Time of heroin use. J Anal Toxicol 2008; 32: 454-6.
32. Cone EJ, Welch P, Paul BD, Mitchell JM,. Forensic drug testing for opiates, III. Urinary excretion rates of morphine and codeine following codeine administration. J Anal Toxicol 1991; 15: 161-6.
33. Lafolie P, Beck O, Lin Z, Albertioni F, Boreus L,. Urine and plasma pharmacokinetics of codeine in healthy volunteers: implications for drugs of abuse testing. J Anal Toxicol 1996; 20: 541-6.
34. United Nations. Recommended Methods for the Detection and Assay of Heroin, Cannabinoids, Cocaine, Amphetamine and Ring-Substituted Amphetamine Derivatives in Biological Specimens. Manual for use by National Laboratories, United Nations, New York, 1995.
35. Smith ML, Shimomura ET, Summers J, et al. Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin. J Anal Toxicol 2001; 25: 504-14.
36. Coles R, Kushnir MM, Nelson GJ, McMillin GA, Urry FM,. Simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, oxycodone, and 6-acetylmorphine in urine, serum, plasma, whole blood, and meconium by LC-MS-MS. J Anal Toxicol 2007; 31: 1-14.
37. Goldberger BA, Darwin WD, Grant TM, Allen AC, Caplan YH, Cone EJ,. Measurement of heroin and its metabolites by isotope-dilution electron-impact mass spectrometry. Clin Chem 1993; 39: 670-5.
38. ONeal CL, Poklis A,. The detection of acetylcodeine and 6-acetylmorphine in opiate positive urines. Forensic Sci Int 1998; 95: 1-10.
39. Staub C, Marset M, Mino A, Mangin P,. Detection of acetylcodeine in urine as an indicator of illicit heroin use: method validation and results of a pilot study. Clin Chem 2001; 47: 301-7.
40. Bogusz MJ, Maier RD, Erkens M, Kohls U,. Detection of non-prescription heroin markers in urine with liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J Anal Toxicol 2001; 25: 431-8.
41. McLachlan-Troup N, Taylor GW, Trathen BC,. Diamorphine treatment for opiate dependence: putative markers of concomitant heroin misuse. Addict Biol 2001; 6: 223-31.
42. Paterson S, Lintzeris N, Mitchell TB, Cordero R, Nestor L, Strang J,. Validation of techniques to detect illicit heroin use in patients prescribed pharmaceutical heroin for the management of opioid dependence. Addiction 2005; 100: 1832-9.
43. Fuller DC, Anderson WH,. A simplified procedure for the determination of free codeine, free morphine, and 6-acetylmorphine in urine. J Anal Toxicol 1992; 16: 315-8.
44. Jones AW, Holmgren A, Kugelberg FC,. Driving under the influence of opiates: concentration relationships between morphine, codeine, 6-acetylmorphine, and ethyl morphine in blood. J Anal Toxicol 2008; 32: 265-72.
45. Carroll FT, Marraccini JV, Lewis S, Wright W,. Morphine-3-D- glucuronidestability in postmortem specimens exposed to bacterial enzymatic hydrolysis. Am J Forensic Med Pathol 2000; 21: 323-9.
46. Skopp G, Potsch L, Klingmann A, Mattern R,. Stability of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in fresh blood and plasma and postmortem blood samples. J Anal Toxicol 2001; 25: 2-7.
47. Fuller DC,. A statistical approach to the prediction of verifiable heroin use from total codeine and total morphine concentrations in urine. J Forensic Sci 1997; 42: 685-9.
48. Lin DL, Chen CY, Shaw KP, et al. Distribution of codeine, morphine and 6-acetylmorphine in vitreous humor. J Anal Toxicol 1997; 21: 258-61.
49. Christophersen AS, Ceder G, Kristinsson J, Lillsunde P, Stenntoft A,. Drugged driving in the Nordic countries-a comparative study between five countries. Forensic Sci Int 1999; 106: 173-90.
50. Jones AW,. Heroin use by motorists in Sweden confirmed by analysis of 6-acetylmorphine in urine [Letter]. J Anal Toxicol 2001; 25: 353-5.
51. Moriya F, Chan KM, Hashimoto Y,. Concentrations of morphine and codeine in urine of heroin abusers. Leg Med (Tokyo) 1999; 1: 140-4.
52. El-Sohly MA, Jones AB,. Morphine and codeine in biological fluids: approaches to source differentiation. Forensic Sci Rev 1989; 1: 13-21.
53. Gerostamoulos J, Staikos V, Drummer OH,. Heroin-related deaths in Victoria: a review of cases for 1997 and 1998. Drug Alcohol Depend 2001; 61: 123-7.
54. Hand CW, Moore RA, Sear JW,. Comparison of whole blood and plasma morphine. J Anal Toxicol 1988; 12: 234-5.
55. Yue QY, Svensson JO, Sjoqvist F, Sawe J,. A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine. Br J Clin Pharmacol 1991; 31: 643-7.
56. Romberg RW, Lee L,. Comparison of the hydrolysis rates of morphine-3-glucuronide and morphine-6-glucuronide with acid and β-glucuronidase. J Anal Toxicol 1995; 19: 157-62.
57. Hackett LP, Ilett KF, Chiswell GM,. Optimizing the hydrolysis of codeine and morphine glucuronides in urine. Ther Drug Monit 2002; 24: 652-7.
58. Hayes LW, Krasselt WG, Mueggler PA,. Concentrations of morphine and codeine in serum and urine after ingestion of poppy seeds. Clin Chem 1987; 33: 806-8.
59. Paul BD, Dreka C, Knight ES, Smith ML,. Gas chromatographic/mass spectrometric detection of narcotine, papaverine and thebaine in seeds of Papaver somniferum. Planta Med 1996; 62: 544-7.